Pharma-Bio Serv (PBSV) Cash from Discontinued Operations (2018)
Pharma-Bio Serv's (PBSV) quarterly Cash from Discontinued Operations came in at $325159.0 in Q4 2018, down 41.85% quarter-over-quarter from $559219.0 in Q3 2018.
Powered by 
Analysis
Pharma-Bio Serv (PBSV) Cash from Discontinued Operations (2018) Analysis & Trends
Pharma-Bio Serv (PBSV) has reported Cash from Discontinued Operations for 1 consecutive years, with $325159.0 the latest figure, recorded in Q4 2018.
- For the quarter ending Q4 2018, Cash from Discontinued Operations changed N/A year-over-year to $325159.0; the trailing twelve-month figure through Jul 2019 stood at $325159.0 (changed N/A YoY), and the FY2018 full-year result was $728726.0, up 192.75% from the prior year.
- Cash from Discontinued Operations slipped to $325159.0 in Q4 2018 per PBSV's latest filing, from $559219.0 in the prior quarter.
- Across five years, Cash from Discontinued Operations topped out at $559219.0 in Q3 2018 and bottomed at -$277995.0 in Q2 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 124.62 Bn | 115.58 Bn | 6.13 Bn | - |
| 2 | UL Solutions | 14.92 Bn | 14.51 Bn | 417.00 Mn | - |
| 3 | Gartner | 11.76 Bn | 10.28 Bn | 1.19 Bn | - |
| 4 | Tetra Tech | 9.19 Bn | 8.96 Bn | 243.21 Mn | - |
| 5 | Booz Allen Hamilton Holding | 8.76 Bn | 8.22 Bn | 1.46 Bn | - |
| 6 | Genpact | 6.27 Bn | 5.75 Bn | 490.34 Mn | - |
| 7 | Korn Ferry | 4.28 Bn | 3.15 Bn | 685.99 Mn | - |
| 8 | Fti Consulting | 4.20 Bn | 4.04 Bn | 316.27 Mn | - |
| 9 | Grand Canyon Education | 4.01 Bn | 3.73 Bn | 204.08 Mn | - |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Oct 31, 2018 | 325,159.00 |
| Jul 31, 2018 | 559,219.00 |
| Apr 30, 2018 | -277,995.00 |
| Jan 31, 2018 | 122,343.00 |